Johnson & Johnson Vision receives FDA clearance, CE mark for Veritas phaco system
Johnson & Johnson Vision has received FDA 510(k) clearance and a CE mark for its Veritas vision system, according to a press release.
The phacoemulsification system includes “technologies that allow surgeons to guide through any lens density with less surge and more stability,” the release said. Additionally, the system has enhanced ergonomics to increase usability for surgeons.
“While the phacoemulsification technique has been used successfully for decades, ease of use continues to be the unmet need with cataract surgeons,” Rajesh K. Rajpal, MD, chief medical officer and global head of clinical and medical affairs at Johnson & Johnson Vision, said in the release. “Every aspect of Johnson & Johnson Vision’s new Veritas system was designed to give surgeons an excellent user experience — optimizing features for safety and efficiency, with improvements in two main areas: fluidics and ergonomics.”
The company plans to launch the system globally later this year.
In February, Johnson & Johnson Vision received FDA approval for the Tecnis Eyhance and Tecnis Eyhance toric II IOLs.